STUDY ON CLINICAL CHARACTERISTICS AND ENDOSCOPIC IMAGES OF IRRITATING BOWEL SYNDROME ACCORDING TO ROME IV IN PATIENTS WITH INFLAMMATORY AND GASTRO-DUODELING ULERS INFECTED WITH HELICOBACTER PYLORI

Si Duc Ho1, Thanh Liem Nguyen2, Thi Hong n Huynh3, Thi Yen Nhi Ngo4, Tan Trong Vo2, Tan Cuong Vo4,
1 Bac Lieu General Hospital
2 Can Tho University of Medicine and Pharmacy
3 Can Tho Central General Hospital
4 Can Tho University of Medicine and Pharmacy Hospital

Main Article Content

Abstract

Background: Irritable bowel syndrome is a chronic functional disorder of the lower gastrointestinal tract, diagnosed according to ROME IV criteria. Patients with duodenal ulcers infected with Helicobacter pylori have an increased incidence of irritable bowel syndrome.  Objectives: Describe the clinical characteristics and endoscopic images of patients with irritable bowel syndrome according to ROME IV in patients with Helicobacter pylori infection and gastric ulcers. Subjects and method: 77 patients with duodenal ulcers infected with helicobacter pylori, study design: cross-sectional description. Results: average age 45.6±15.1, men accounted for a higher proportion than women. 100% of patients had symptoms of abdominal pain at least once per week in the last 3 months. Abdominal pain along the colonic framework accounts for 57.1%. Changes in stool characteristics accounted for 90.9%, Irritable bowel syndrome with diarrhea (IBS-D) accounted for a high proportion in our study, accounting for 46.8%. Colonoscopy detected lesions in 14.3%. Conclusion: 100% of patients had symptoms of abdominal pain at least once per week in the last 3 months. Abdominal pain along the colonic framework accounts for 57.1%. Changes in stool characteristics accounted for 90.9%, Irritable bowel syndrome with diarrhea (IBS-D) accounted for a high proportion in our study, accounting for 46.8%. Colonoscopy detected lesions in 14.3%.

Article Details

References

1. Katelaris P, Hunt R, Bazzoli F, et al, Helicobacter pylori World Gastroenterology Organization Global Guideline. J Clin Gastroenterol. 2023 Feb 1. 57(2):111-126, doi: 10.1097/MCG.0000000000001719.
2. Nista EC, Pellegrino A, Giuli L, et al, Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature. Antibiotics (Basel). 2022 Oct 21. 11(10):1452, doi: 10.3390/antibiotics11101452.
3. Defrees DN, Bailey J. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Prim Care. 2017 Dec. 44(4):655-671, doi: 10.1016/j.pop.2017.07.009. Epub 2017 Oct 5. PMID: 29132527.
4. Liang CM, Hsu CH, Chung CH, et al, Risk for Irritable Bowel Syndrome in Patients with Helicobacter Pylori Infection: A Nationwide Population-Based Study Cohort Study in Taiwan.
Int J Environ Res Public Health. 2020 May 25. 17(10):3737, doi: 10.3390/ijerph17103737.
5. Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017 Apr 30. 23(2), 151-163, doi: 10.5056/jnm16214.
6. Keo Soly, Huỳnh Kim Phượng, Huỳnh Hiếu Tâm, Đặc điểm lâm sàng và hình ảnh nội soi đại tràng bệnh nhân có hội chứng ruột kích thích theo tiêu chuẩn Rome IV. Tạp chí Y Dược học Cần Thơ. 2022. Số 51. 34-41.
7. Trần Thị Khánh Tường. Tần suất có tổn thương đại tràng ở bệnh nhân có triệu chứng của hội chứng ruột kích thích theo ROME IV. Tạp chí Y học Việt Nam. 2020. Tập 489, số 1, 2020. 11-15.
8. Amin HS, Irfan F, Karim SI, et alo, The prevalence of irritable bowel syndrome among Saudi population in Riyadh by use of Rome IV criteria and self-reported dietary restriction. Saudi J Gastroenterol. 2021 Nov-Dec. 27(6), 383-390, doi: 10.4103/sjg.sjg_43_21.
9. Zeeshan MH, Vakkalagadda NP, Sree GS, et al, Irritable bowel syndrome in adults: Prevalence and risk factors. Ann Med Surg (Lond). 2022 Aug 19,81, 104408, doi:
10.1016/j.amsu.2022.104408.
10. Nguyễn Thủy Bích, Phan Trung Nam. Tỷ lệ mắc và một số yếu tố liên quan hội chứng ruột kích thích ở sinh viên y khoa trường đại học y dược, Tạp chí Y dược học - Trường Đại học Y dược Huế. 2020, số 5, 11-17.